ADC Therapeutics (ADCT) Non Operating Income (2021 - 2026)
ADC Therapeutics (ADCT) posted Non Operating Income of -$7.7 million for Q1 2026, up 22.75% sequentially from -$10.0 million in Q3 2025, and up 22.56% YoY from -$6.3 million in Q1 2025.
ADC Therapeutics (ADCT) Non Operating Income (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Non Operating Income for 6 years, with the latest figure at -$7.7 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn | 8.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.85 Mn |
| Mar 31, 2026 | -7.72 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | -11.25 Mn |
| Mar 31, 2025 | -9.97 Mn |
| Sep 30, 2024 | -8.06 Mn |
| Jun 30, 2024 | -6.67 Mn |
| Mar 31, 2024 | -12.14 Mn |
| Sep 30, 2023 | -9.25 Mn |
| Jun 30, 2023 | -13.00 Mn |
| Mar 31, 2023 | -3,000.00 |
| Sep 30, 2022 | -37.12 Mn |
| Jun 30, 2022 | 12.88 Mn |
| Mar 31, 2022 | 13.44 Mn |
| Sep 30, 2021 | -9.36 Mn |
| Jun 30, 2021 | 693,000.00 |
| Mar 31, 2021 | 21.23 Mn |